These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26748011)

  • 1. The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir.
    Phillips AM; Shoulders MD
    J Mol Biol; 2016 Feb; 428(3):533-537. PubMed ID: 26748011
    [No Abstract]   [Full Text] [Related]  

  • 2. Oseltamivir analogues bearing N-substituted guanidines as potent neuraminidase inhibitors.
    Mooney CA; Johnson SA; 't Hart P; Quarles van Ufford L; de Haan CA; Moret EE; Martin NI
    J Med Chem; 2014 Apr; 57(7):3154-60. PubMed ID: 24649802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peramivir. A new and potent neuraminidase inhibitor for the treatment of influenza].
    Reina J
    Rev Esp Quimioter; 2006 Dec; 19(4):317-22. PubMed ID: 17235399
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of neuraminidase inhibitors for the treatment of influenza A virus infections].
    Ferraris O; Escuret V; Bouscambert-Duchamp M; Lina B; Morfin F
    Pathol Biol (Paris); 2010 Apr; 58(2):e69-78. PubMed ID: 20303677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virology. Helping the resistance.
    Holmes EC
    Science; 2010 Jun; 328(5983):1243-4. PubMed ID: 20522766
    [No Abstract]   [Full Text] [Related]  

  • 6. A Balance between Inhibitor Binding and Substrate Processing Confers Influenza Drug Resistance.
    Jiang L; Liu P; Bank C; Renzette N; Prachanronarong K; Yilmaz LS; Caffrey DR; Zeldovich KB; Schiffer CA; Kowalik TF; Jensen JD; Finberg RW; Wang JP; Bolon DNA
    J Mol Biol; 2016 Feb; 428(3):538-553. PubMed ID: 26656922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oseltamivir-resistant influenza?
    Moscona A
    Lancet; 2004 Aug 28-Sep 3; 364(9436):733-4. PubMed ID: 15337382
    [No Abstract]   [Full Text] [Related]  

  • 8. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.
    Ives JA; Carr JA; Mendel DB; Tai CY; Lambkin R; Kelly L; Oxford JS; Hayden FG; Roberts NA
    Antiviral Res; 2002 Aug; 55(2):307-17. PubMed ID: 12103431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)".
    Rungrotmongkol T; Malaisree M; Udommaneethanakit T; Hannongbua S
    Biophys Chem; 2009 Apr; 141(1):131-2; author reply 133. PubMed ID: 19231807
    [No Abstract]   [Full Text] [Related]  

  • 10. 1,2,3-Triazolyl-4-oxoquinolines: A feasible beginning for promising chemical structures to inhibit oseltamivir-resistant influenza A and B viruses.
    Boechat Fda C; Sacramento CQ; Cunha AC; Sagrillo FS; Nogueira CM; Fintelman-Rodrigues N; Santos-Filho O; Riscado CS; Forezi Lda S; Faro LV; Brozeguini L; Marques IP; Ferreira VF; Souza TM; de Souza MC
    Bioorg Med Chem; 2015 Dec; 23(24):7777-84. PubMed ID: 26643220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance. A 'wimpy' flu strain mysteriously turns scary.
    Enserink M
    Science; 2009 Feb; 323(5918):1162-3. PubMed ID: 19251605
    [No Abstract]   [Full Text] [Related]  

  • 12. Dextran sulfate-resistant A/Puerto Rico/8/34 influenza virus is associated with the emergence of specific mutations in the neuraminidase glycoprotein.
    Yamada H; Nagao C; Haredy AM; Mori Y; Mizuguchi K; Yamanishi K; Okamoto S
    Antiviral Res; 2014 Nov; 111():69-77. PubMed ID: 25234090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and structural analysis of influenza virus neuraminidase N3 offers further insight into the mechanisms of oseltamivir resistance.
    Li Q; Qi J; Wu Y; Kiyota H; Tanaka K; Suhara Y; Ohrui H; Suzuki Y; Vavricka CJ; Gao GF
    J Virol; 2013 Sep; 87(18):10016-24. PubMed ID: 23824808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo.
    Carr J; Ives J; Kelly L; Lambkin R; Oxford J; Mendel D; Tai L; Roberts N
    Antiviral Res; 2002 May; 54(2):79-88. PubMed ID: 12062393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistant influenza A viruses in children treated with oseltamivir: descriptive study.
    Kiso M; Mitamura K; Sakai-Tagawa Y; Shiraishi K; Kawakami C; Kimura K; Hayden FG; Sugaya N; Kawaoka Y
    Lancet; 2004 Aug 28-Sep 3; 364(9436):759-65. PubMed ID: 15337401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on 'Comment on "Another look at the molecular mechanism of the resistance of H5N1 influenza A virus neuraminidase (NA) to oseltamivir (OTV)"'.
    Mitrasinovic PM
    Biophys Chem; 2011 Mar; 154(2-3):102. PubMed ID: 21316835
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis and in vitro study of novel neuraminidase inhibitors against avian influenza virus.
    Kongkamnerd J; Cappelletti L; Prandi A; Seneci P; Rungrotmongkol T; Jongaroonngamsang N; Rojsitthisak P; Frecer V; Milani A; Cattoli G; Terregino C; Capua I; Beneduce L; Gallotta A; Pengo P; Fassina G; Miertus S; De-Eknamkul W
    Bioorg Med Chem; 2012 Mar; 20(6):2152-7. PubMed ID: 22342267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
    Zhang J; Murugan NA; Tian Y; Bertagnin C; Fang Z; Kang D; Kong X; Jia H; Sun Z; Jia R; Gao P; Poongavanam V; Loregian A; Xu W; Ma X; Ding X; Huang B; Zhan P; Liu X
    J Med Chem; 2018 Nov; 61(22):9976-9999. PubMed ID: 30365885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sensitivity of the epidemic and pandemic influenza virus strains to zanamivir (Relenze) in in vitro experiments].
    L'vov DK; Burtseva EI; Galegov GA; Beliakova NV; Shevchenko ES; Kolobukhina LV; Merkulova LN; Prilipov AG; Leneva IA; Baranov NI; Gorelikov VN; Abramov DD
    Vopr Virusol; 2010; 55(6):10-4. PubMed ID: 21381333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.